On February 27, 2018 VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) disorders, reported that Shawn Singh, Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference in Boston at 10:00 a.m. Eastern Time on Wednesday, March 14, 2018 (Press release, VistaGen Therapeutics, FEB 27, 2018, View Source [SID1234524267]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be accessible at the time of the presentation on the investor page of VistaGen’s website at ir.vistagen.com. A replay of the webcast will be archived on VistaGen’s website following the conference.

For more information about the conference, or to schedule a one-on-one meeting with VistaGen’s management, please contact your Cowen representative directly, or send an email to [email protected].